Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study

• Published in: Current controlled trials in cardiovascular medicine Vol. 20; no. 1; p. 741
• Main Authors: Liu, Chien-Ting, Chen, Yen-Hao, Huang, Yu-Chuen, Chen, Shih-Yu, Tsai, Ming-Yen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 17.12.2019; BioMed Central; BMC
• Subjects: Abdomen; Adjuvant chemotherapy; Analysis; Asian medicine; Breast cancer; Cancer patients; Cancer prevention; Cancer research; Cancer therapies; Care and treatment; Chemotherapy; Chinese medicine; Clinical trials; Cohort analysis; Disease-free survival; Herbal medicine; Liver; Medical prognosis; Medical research; Patient outcomes; Patients; Prognosis; Quality of life; Study design; Study Protocol; Surgery; Tongue; Traditional Chinese medicine; Women's health; China; Taiwan; Study design; Traditional Chinese medicine; Breast cancer; Disease-free survival; Quality of life
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-019-3848-8

Chemotherapy after surgery for breast cancer plays a fundamental role in reducing the risk of distant and local recurrence. An increasing number of patients seek traditional Chinese medicine (TCM) during adjuvant chemotherapy to relieve symptom discomfort and side effects as well as to strengthen the body's defenses. However, evidence on how concurrent TCM treatment affects prognosis is scarce. This trial aims to evaluate the association between TCM treatment and disease-free survival outcomes for patients with early breast cancer who are undergoing adjuvant chemotherapy. This is a non-randomized, single center, prospective cohort study begun in November 2018 in Kaohsiung, Taiwan. A sample of 310 participants diagnosed with early breast cancer was recruited from the Breast Cancer Research Team and will be followed up every 3 to 6 months until October 2023. Detailed information of the participants, including general information, history of cancer, quality of life, side effects and safety of treatment, TCM body constitution, and meridian energy analysis, was collected face to face at baseline. This is the first prospective observational cohort study on TCM in patients with early breast cancer who are receiving adjuvant chemotherapy to evaluate the prognosis. Through this trial, we hope to assess the feasibility of a larger-scale clinical trial in the future and formulate an integrated TCM care program. ClinicalTrials.gov, NCT03797248. Registered on 5 January 2019.